This topic contains a solution. Click here to go to the answer

Author Question: The industry average P/E for the athletics and apparel industry is 18.8. Estimate the fair value of ... (Read 107 times)

roselinechinyere27m

  • Hero Member
  • *****
  • Posts: 557
The industry average P/E for the athletics and apparel industry is 18.8. Estimate the fair value of Nike's shares based on the industry average multiple and the data supplied in the table, below.
 
  Price 65
  EPS 3
  Debt 545M
  Equity 9,087M
  Cash 3,630M
  EBITDA 2,770M
  Shares 487M
 
  A) 11.43
  B) 56.40
  C) 65.00
  D) 68.00
  E) 87.50

Question 2

The Truth in Savings Law requires banks to advertise their rates on investments such as CDs and savings accounts as annual percentage yields (APY).
 
  Indicate whether the statement is true or false.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Edwyer

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

B

Answer to Question 2

Answer: TRUE




roselinechinyere27m

  • Member
  • Posts: 557
Reply 2 on: Jul 10, 2018
Wow, this really help


raenoj

  • Member
  • Posts: 340
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

Famous people who died from poisoning or drug overdose include, Adolf Hitler, Socrates, Juan Ponce de Leon, Marilyn Monroe, Judy Garland, and John Belushi.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library